NR1D1 and Duchenne muscular dystrophy: By itself, and consistent with results from other studies showing that improving Ca2+ homeostasis mitigates DMD (7, 22), we can hypothesize that pharmacological NR1D1 activation reduces MLN expression, which may partly contribute to the improved muscle contractility observed in myopathic mice.